Aβ-Immunotherapy for Alzheimer's Disease Using Mannan–Amyloid-Beta Peptide Immunoconjugates

In Alzheimer's disease (AD) the accumulation of pathological forms of the beta-amyloid (Aβ) peptide are believed to be causal factors in the neurodegeneration that results in the loss of cognitive function in patients. Anti-Aβ antibodies have been shown to reduce Aβ levels in transgenic mouse m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: GHOCHIKYAN, ANAHIT, PETRUSHINA, IRINA, LEES, ANDREW, VASILEVKO, VITALY, MOVSESYAN, NINA, KARAPETYAN, ADRINE, AGADJANYAN, MICHAEL G., CRIBBS, DAVID H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2006
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2048489/
https://ncbi.nlm.nih.gov/pubmed/17132088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dna.2006.25.571
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak